Tesla’s European Breakthrough Can’t Mask the $25 Billion Cash Drain

Tesla beats Q1 earnings estimates but faces a $25 billion capital expenditure forecast, negative free cash flow, and a stock decline as it invests heavily in factories and AI chips.

The electric vehicle maker delivered a first-quarter earnings beat that should have been cause for celebration. Instead, investors are staring down a capital expenditure shock that threatens to swallow the company’s cash flow for the foreseeable future.

A Quarter of Contradictions

Tesla reported adjusted earnings of 41 cents per share for the first quarter of 2026, surpassing analyst estimates by 14 percent. The automotive gross margin rebounded sharply to 21.1 percent, a figure that would typically send the stock higher. Revenue came in at roughly $22.4 billion, slightly below expectations, while one-time items tied to tariffs and warranty adjustments flattered the bottom line.

Yet the stock closed at €322.90 on Tuesday, leaving it down roughly 14 percent since the start of the year. The relative strength index sits at 34, flirting with oversold territory. The culprit? A capital expenditure forecast that has Wall Street questioning whether Tesla is building a future or burning its present.

The $25 Billion Question

Chief Financial Officer Vaibhav Taneja dropped the bombshell on the earnings call: Tesla now expects to spend more than $25 billion on capital investments this year. That figure has nearly tripled from the $8.6 billion deployed in 2025 and represents a sharp upward revision from the $20 billion guidance given just one quarter ago. The first quarter alone saw capex jump 67 percent year-over-year to $2.49 billion.

The consequence is stark. Management has signaled that free cash flow will turn negative for the remainder of 2026 as the company pours money into six new factories, a dedicated chip fabrication facility, and expanded artificial intelligence infrastructure.

In Texas, production of the Cybercab has officially begun, though Elon Musk has cautioned that meaningful revenue from the robotaxi fleet won’t materialize until 2027, pending regulatory approval for fully autonomous vehicles without steering wheels. On the same Austin campus, Tesla is building a $3 billion research fab dubbed Terafab, where it plans to manufacture AI chips using Intel’s forthcoming 14A process technology. Musk cited concerns about supply constraints from external vendors as the rationale for bringing semiconductor production in-house.

A European Door Opens

Amid the spending frenzy, Tesla secured a landmark regulatory victory. The Dutch vehicle authority RDW granted type approval for FSD Supervised version 2026.3.6 on April 10, following an 18-month testing period. The approval is based on UN Regulation 171, the European standard for Level 2 driver assistance systems. Drivers may take their hands off the wheel but remain legally responsible at all times, with eye-tracking cameras monitoring attention and a fail-safe mechanism that brings the vehicle to a controlled stop if warnings are ignored.

The pricing structure for the Dutch market has been set at €99 per month for the standard subscription, €49 for Enhanced Autopilot owners, or €7,500 as a one-time purchase.

The RDW approval is designed as a regulatory template for the entire European Union. Through mutual recognition, all member states can adopt the Dutch certification without undergoing full re-approval. A broader EU decision from the Technical Committee for Motor Vehicles could come as early as May or June. Tesla plans a phased rollout beginning in the Netherlands this month, followed by Germany, France, Belgium, Spain, and Italy by the summer.

The company is also casting a wider net. Job postings for FSD test drivers have appeared in Seoul, Bangkok, Mumbai, Riyadh, Istanbul, and several Eastern European cities, following the familiar pattern of local data collection, then regulatory engagement, then customer release. Talks with Chinese regulators remain ongoing, and a green light there would represent a significant commercial milestone given the market’s size.

Subscriptions Surge, But Skepticism Lingers

The bull case found ammunition in the first-quarter numbers beyond the earnings beat. Active FSD subscriptions climbed to 1.28 million, a 51 percent increase year-over-year. That metric suggests growing customer appetite for Tesla’s autonomous features, even as the company struggles to convert that interest into near-term profitability from autonomy.

Bears have their own data points. Energy revenue declined 12 percent, and vehicle inventory levels are rising. The margin improvement, while welcome, has drawn skepticism from analysts who question its sustainability. Needham maintained a hold rating, warning that the current margin profile may not be repeatable.

Wall Street’s Divide Widens

The analyst community remains deeply split on Tesla’s trajectory. Dan Ives at Wedbush holds firm with a $600 price target, arguing that the aggressive spending is essential for Tesla’s AI ambitions. RBC Capital trimmed its target slightly to $475, citing risks around the Optimus humanoid robot program, but kept a buy rating. On the pessimistic end, some analysts value Tesla purely as an automaker, with a price target as low as $220. The optimists, pricing in Cybercab, Optimus, and robotaxi revenue as nascent growth options, see the stock worth $428.

Morgan Stanley characterized the investment cycle as necessary for building a durable leadership position in autonomy and physical AI, but cautioned that the elevated spending combined with a measured rollout of AI programs will cap near-term share price appreciation.

JPMorgan flagged an additional risk: regulatory environmental credits, which have poured billions into Tesla’s coffers, could be cut in half by 2027 due to potential policy changes in the United States.

The Clock Is Ticking

Tesla is making a calculated bet that short-term financial pain will yield long-term dominance in autonomous transportation and robotics. The European FSD approval represents the most concrete step yet toward justifying the premium valuation that autonomy believers have assigned to the stock. But the timeline for meaningful revenue from self-driving technology remains the critical unknown.

The company has set a marker for July 2026, when production of the Optimus humanoid robot is scheduled to begin. By then, management will need to demonstrate that the largest capital allocation in Tesla’s history is beginning to generate commercial returns. Until that proof arrives, the $25 billion question will hang over every earnings report.